Shanghai Shyndec Pharmaceutical (600420.SH) : The Injection of Pentobarbital Sodium has obtained a drug registration certificate.

Shanghai Shyndec Pharmaceutical (600420.SH) announced recently that its wholly-owned subsidiary, Guoyao Group Industry Co., Ltd. (referred to as Guoyao Industry), has received the drug registration certificate for the injection of Tertatolol Hydrochloride approved and issued by the National Medical Products Administration. Tertatolol Hydrochloride injection is a selective anticholinergic drug, mainly used for pre-anesthesia to inhibit the secretion of salivary glands and airway glands, as well as for the emergency treatment of organophosphorus (pesticide) poisoning and for the maintenance of atropine after poisoning or cholinesterase (ChE) aging. The Tertatolol Hydrochloride injection (1ml:1mg) from Guoyao Industry has obtained the drug registration certificate and is deemed to have passed consistency evaluation. This will further enrich the company's product portfolio, strengthen the company's overall market competitiveness, and have a positive impact on the company's future development. The above matters will not have a significant impact on the company's current business performance.